Hypertension and Cardiac Progenitors

Hypertension (HTN or HT), also known as high blood pressure, is a long term medical condition in which the blood pressure in the arteries is persistently elevated.[1] High blood pressure usually does not cause symptoms.[2] Long term high blood pressure; however, is a major risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease.Cardiac progenitor cells (CPCs) are committed to the cardiac lineage but retain their proliferative capacity before becoming quiescent mature cardiomyocytes (CMs). In medical therapy and research, the use of human pluripotent stem cell-derived CPCs would have several advantages compared with mature CMs, as the progenitors show better engraftment into existing heart tissues, and provide unique potential for cardiovascular developmental as well as for pharmacological studies. Cardiac progenitor cells (CPCs) represent the earliest stages of mesoderm commitment to the cardiac lineages and directed differentiation of CPCs from pluripotent stem cells has been demonstrated in a number of recent studies. Furthermore, these cells have been shown to be capable of generating other terminal cardiac cell types such as cardiomyocytes, endothelial cells, and vascular smooth muscle cells.  However, utilization of CPCs for such endeavors requires a robust, scalable, and consistent differentiation methodology.

Related Conferences

7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Echo Cardiography Conference June 06-07, 2016 London, UK; Ischemic Heart Diseases Conference May 12-13, 2016 Chicago, USA; 8th Global Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Drug Discovery and Therapy World Congress May 11-14, 2016, Boston, USA; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

  • Embryonic stem cells
  • Pluripotent stem cells
  • Cardiogenesis
  • Cardiac differentiation
  • Cardiac development
  • Hematopoietic progenitors

Related Conference of Hypertension and Cardiac Progenitors

December 09-10, 2024

3rd International Conference on Cardiology

Dubai, UAE
December 10-11, 2024

6th Euro Cardiology Congress

Dubai, UAE
December 12-13, 2024

13th World Heart Congress

Rome, Italy
December 12-13, 2024

5th Global Summit on Heart Congress

Dubai, UAE
December 26-27, 2024

28th World Cardiology Conference

Paris, France
February 20-21, 2025

35th International Conference on Cardiology and Healthcare

Amsterdam, Netherlands
February 20-21, 2025

14th World Congress on Cardiology

Amsterdam, Netherlands
February 24-25, 2025

40th World Cardiology Conference

London, UK
February 27-28, 2025

4th Global Summit on Cardiology and Cardiac Surgery

Paris, France
March 24-25, 2025

14th World Heart Congress

Paris, France
April 16-17, 2025

8th World Heart and Brain Conference

Tokyo, Japan
April 24-25, 2025

9th Annual Heart Rhythm Conference

Vienna, Austria
May 22-23, 2025

5th World Congress on Congestive Heart Failure & Angina

Zurich, Switzerland
May 26-27, 2025

6th European Summit on Cardiology Research

Rome, Italy
August 21-22, 2025

8th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Hypertension and Cardiac Progenitors Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in